Home › Funds › Long Focus Capital Management, LLC › BCYC

Long Focus Capital Management, LLC position in BCYC

BICYCLE THERAPEUTICS PLC · Health Care

Long Focus Capital Management, LLC reported holding 3,310,687 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$14.0M, representing 0.56% of its reported portfolio and ranking #50 among its reported holdings. Long Focus Capital Management, LLC has disclosed BCYC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)3.31M sh
Reported value held$14.04M
Portfolio Weight0.56%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Long Focus Capital Management, LLC's BCYC position evolved

Long Focus Capital Management, LLC first disclosed a stake in BCYC in Q4 2024 at 543,092 shares (US$7.6M). The position peaked in Q1 2026 at 3,310,687 shares, worth US$15.4M. Across 7 filings, Long Focus Capital Management, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,310,687 shares valued at US$14.0M. Notable position changes include a 138% increase in Q1 2025 (shares fell 18% over the following quarter), a 103% increase in Q1 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 543.09K $7.60M New
Q1 2025 1.29M $10.98M Add
Q2 2025 1.32M $9.16M Add
Q3 2025 1.42M $10.98M Add
Q4 2025 1.63M $11.56M Add
Q1 2026 3.31M $15.36M Add
Q2 2026 3.31M $14.04M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCYC and 13F data

BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 10 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), GSK plc (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCYC

All BCYC fund holders →

FAQ

How long has Long Focus Capital Management, LLC held BCYC?

Long Focus Capital Management, LLC has disclosed BCYC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Long Focus Capital Management, LLC's current position in BCYC?

As of Q2 2026, Long Focus Capital Management, LLC holds 3.31M shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $14.04M, representing 0.56% of its reported portfolio and ranking #50.

Has Long Focus Capital Management, LLC been buying or selling BCYC?

In the latest 13F filing (Q2 2026), Long Focus Capital Management, LLC held unchanged its position in BCYC. The position peaked in Q1 2026 at 3.31M shares.

Which other funds hold BCYC?

Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., GSK plc, among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.